Literature DB >> 31472929

Long-term cardiovascular health after stopping pre-eclampsia.

Anne Cathrine Staff1.   

Abstract

Mesh：

Year:  2019        PMID： 31472929     DOI： 10.1016/S0140-6736(19)31993-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Development and Validation of Multi-Stage Prediction Models for Pre-eclampsia: A Retrospective Cohort Study on Chinese Women.

Authors:  Zeyu Tang; Yuelong Ji; Shuang Zhou; Tao Su; Zhichao Yuan; Na Han; Jinzhu Jia; Haijun Wang
Journal:  Front Public Health       Date:  2022-05-30

2.  The Novel Peptide AEDPPE Alleviates Trophoblast Cell Dysfunction Associated With Preeclampsia by Regulating the NF-κB Signaling Pathway.

Authors:  Yixiao Wang; Yan Cao; Xiaohong Ji; Ting Li; Lu Xue; Chanjuan Li; Ruizhe Jia; Hongjuan Ding
Journal:  Front Cardiovasc Med       Date:  2021-12-17

3.  Cost-Utility Analysis of Planned Early Delivery or Expectant Management for Late Preterm Pre-eclampsia (PHOENIX).

Authors:  Rachael Hunter; Alice Beardmore-Gray; Melanie Greenland; Louise Linsell; Edmund Juszczak; Pollyanna Hardy; Anna Placzek; Andrew Shennan; Neil Marlow; Lucy C Chappell
Journal:  Pharmacoecon Open       Date:  2022-07-21

4.  Overexpression of let-7d explains down-regulated KDM3A and ENO2 in the pathogenesis of preeclampsia.

Authors:  Qian Xu; Yonghui Song; Lili Lu
Journal:  J Cell Mol Med       Date:  2021-08-05       Impact factor: 5.310
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.